Imaging software developer Median Technologies has announced that it will collaborate with contract research organization CMIC Holdings to provide imaging technologies, services, and expertise to biopharmaceutical companies in Asia.
The imaging technologies and services of Median will facilitate the development of oncology drugs and therapies in comprehensive clinical trials led by various companies in Japan, China, and East Asia, Median said.
